IL17AaptamersIL17

Anastasiya Solovieva1, Dariya Rippinen1, Anna Davydova2

  • 1Research Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, 630117 Novosibirsk, Russia.

PubMed
概括

向INTERLEUKIN-17A (IL-17A) 和其受体的寡核酸聚体显示出作为治疗炎症关节病的单克隆抗体的替代品的希望. 在细胞模型中,这些胺酶有效地抑制了IL-17A诱导的炎症,这表明了脊髓关节炎治疗的潜力.